Loading…
Colgate Palmolive (India) (COLPAL)₹1,695+0.13%Personal Care
In the Jun 2026 quarter (standalone), Colgate Palmolive (India) reported sales of ₹1,597 Cr, up 11.8% from Jun 2025, and net profit of ₹343 Cr, up 6.9% year on year. For the year to Mar 2026, sales were ₹6,017 Cr and net profit ₹1,325 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,466 | 1,391 | 1,484 | 1,492 | 1,613 | 1,458 | 1,459 | 1,429 | 1,516 | 1,482 | 1,590 | 1,597 |
| Expenses | 986 | 924 | 956 | 985 | 1,119 | 1,005 | 962 | 979 | 1,051 | 1,042 | 1,084 | 1,118 |
| Operating Profit | 482 | 468 | 532 | 509 | 497 | 454 | 499 | 453 | 465 | 442 | 510 | 483 |
| OPM % | 33.0% | 34.0% | 36.0% | 34.0% | 31.0% | 31.0% | 34.0% | 32.0% | 31.0% | 30.0% | 32.0% | 30.0% |
| Other Income | 20.99 | 17.97 | 22.97 | 22.96 | 75.95 | 19.99 | 18.99 | 17.99 | 14.98 | 30.97 | 0.00 | 18.98 |
| Interest | 1.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Depreciation | 44.07 | 41.07 | 42.08 | 42.07 | 42.04 | 41.08 | 38.07 | 38.04 | 37.07 | 36.07 | 35.03 | 39.03 |
| Profit before tax | 459 | 444 | 512 | 490 | 531 | 433 | 479 | 433 | 443 | 437 | 475 | 463 |
| Tax % | 26.0% | 26.0% | 26.0% | 26.0% | 26.0% | 25.0% | 26.0% | 26.0% | 26.0% | 26.0% | 25.0% | 26.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −5.99 | −11.97 | −1.99 |
| Net Profit | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 | 353 | 343 |
| EPS (Rs) | 12.51 | 12.13 | 13.97 | 13.39 | 14.53 | 11.88 | 13.06 | 11.78 | 12.05 | 11.92 | 12.98 | 12.62 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,852 | 3,971 | 4,177 | 4,447 | 4,507 | 4,825 | 5,086 | 5,211 | 5,659 | 6,022 | 6,017 | 6,185 |
| Expenses | 2,923 | 3,029 | 3,067 | 3,217 | 3,315 | 3,325 | 3,526 | 3,669 | 3,771 | 4,073 | 4,157 | 4,295 |
| Operating Profit | 941 | 945 | 1,115 | 1,237 | 1,203 | 1,512 | 1,567 | 1,547 | 1,902 | 1,960 | 1,870 | 1,901 |
| OPM % | 24.0% | 24.0% | 27.0% | 28.0% | 27.0% | 31.0% | 31.0% | 30.0% | 33.0% | 32.0% | 31.0% | 30.7% |
| Other Income | 6.99 | 40.97 | 25.96 | 67.96 | 48.95 | 29.95 | 25.99 | 41.99 | 56.92 | 139 | 63.96 | 64.93 |
| Interest | 0.00 | 0.00 | 0.00 | 2.01 | 10.01 | 7.01 | 6.01 | 5.01 | 5.01 | 4.01 | 4.01 | 4.04 |
| Depreciation | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 146 | 147 |
| Profit before tax | 837 | 853 | 985 | 1,146 | 1,044 | 1,352 | 1,412 | 1,412 | 1,783 | 1,933 | 1,788 | 1,818 |
| Tax % | 30.0% | 32.0% | 32.0% | 32.0% | 22.0% | 23.0% | 23.0% | 26.0% | 26.0% | 26.0% | 26.0% | — |
| Exceptional items | −21.94 | 0.00 | −7.98 | 19.97 | 0.00 | −0.99 | 0.00 | −7.99 | −13.97 | 0.00 | −18.94 | −19.95 |
| Net Profit | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,048 | 1,325 | 1,438 | 1,325 | 1,348 |
| EPS (Rs) | 21.39 | 21.24 | 24.78 | 28.55 | 30.01 | 38.10 | 39.67 | 38.49 | 48.72 | 52.88 | 48.72 | 49.57 |
| Dividend payout % | 47.0% | 47.0% | 97.0% | 81.0% | 93.0% | 100.0% | 101.0% | 101.0% | 119.0% | 97.0% | 119.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.04 | 27.11 | 27.11 | 27.10 | 27.10 | 27.09 | 27.08 | 27.10 | 27.10 | 27.10 | 27.10 | 27.11 |
| Reserves | 759 | 1,006 | 1,250 | 1,500 | 1,423 | 1,569 | 1,141 | 1,709 | 1,693 | 1,852 | 1,639 | 1,561 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 82.74 | 102 | 90.73 | 82.84 | 68.79 | 71.85 | 60.83 | 46.88 |
| Other Liabilities | 933 | 974 | 1,039 | 1,041 | 1,099 | 910 | 1,640 | 1,086 | 1,099 | 1,251 | 1,295 | 1,777 |
| Total Liabilities | 1,704 | 2,007 | 2,316 | 2,568 | 2,631 | 2,608 | 2,899 | 2,906 | 2,888 | 3,203 | 3,023 | 3,413 |
| Fixed Assets | 783 | 1,011 | 1,111 | 1,149 | 1,194 | 1,126 | 1,067 | 965 | 864 | 796 | 778 | 720 |
| CWIP | 141 | 78.24 | 168 | 160 | 200 | 191 | 146 | 122 | 114 | 110 | 38.12 | 27.08 |
| Investments | 37.05 | 31.09 | 31.06 | 31.08 | 31.08 | 19.03 | 19.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 743 | 886 | 1,006 | 1,229 | 1,208 | 1,273 | 1,668 | 1,818 | 1,910 | 2,296 | 2,205 | 2,665 |
| Inventories | 251 | 291 | 292 | 226 | 248 | 296 | 335 | 356 | 334 | 295 | 376 | 375 |
| Trade receivables | 70.03 | 102 | 130 | 201 | 210 | 133 | 117 | 225 | 157 | 167 | 226 | 209 |
| Cash & equivalents | 254 | 289 | 295 | 456 | 399 | 422 | 870 | 756 | 924 | 1,376 | 1,096 | 1,470 |
| Total Assets | 1,704 | 2,007 | 2,316 | 2,568 | 2,631 | 2,608 | 2,899 | 2,906 | 2,888 | 3,203 | 3,023 | 3,413 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 640 | 691 | 689 | 696 | 986 | 933 | 786 | 1,629 | 1,179 | 1,202 | 1,397 | 1,810 |
| Cash from investing activity | −272 | −237 | −342 | −207 | −96.07 | −19.01 | 70.98 | −108 | −8.01 | 78.96 | 55.98 | 374 |
| Cash from financing activity | −384 | −391 | −340 | −379 | −814 | −889 | −954 | −1,089 | −1,086 | −1,193 | −1,668 | −1,419 |
| Net cash flow | −18.06 | 61.14 | 5.02 | 107 | 73.24 | 20.05 | −101 | 428 | 82.21 | 83.29 | −222 | 761 |
| Capex | 300 | 272 | 320 | 208 | 139 | 59.83 | 57.85 | 49.86 | 69.79 | 75.83 | 70.80 | 75.82 |
| Free cash flow | 339 | 416 | 366 | 485 | 877 | 868 | 726 | 1,574 | 1,105 | 1,121 | 1,321 | 1,727 |
| CFO / OP % | 103.0% | 100.0% | 105.0% | 93.0% | 113.0% | 104.0% | 76.0% | 127.0% | 101.0% | 88.0% | 100.0% | 121.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 | 13 |
| Inventory days | 62 | 71 | 71 | 55 | 57 | 68 | 78 | 77 | 67 | 62 | 75 | 74 |
| Days payable | 127 | 135 | 147 | 151 | 143 | 141 | 178 | 168 | 154 | 186 | 184 | 274 |
| Cash conversion cycle | −59 | −55 | −63 | −79 | −68 | −63 | −91 | −75 | −76 | −113 | −95 | −188 |
| Working capital days | −40 | −43 | −39 | −33 | −36 | −23 | −84 | −25 | −32 | −46 | −37 | −59 |
| ROCE % | 114.1% | 96.0% | 74.1% | 71.1% | 73.0% | 65.0% | 92.0% | 92.0% | 79.0% | 97.0% | 105.0% | 108.1% |
For the Jun 2026 quarter, Colgate Palmolive (India) reported sales of ₹1,597 Cr, up 11.8% year on year and net profit of ₹343 Cr, up 6.9% year on year. The operating margin was 30.0%.
Colgate Palmolive (India)'s sales for the year to Mar 2026 were ₹6,017 Cr; over the last twelve months they were ₹6,185 Cr.
Net profit for the year to Mar 2026 was ₹1,325 Cr, and ₹1,348 Cr over the last twelve months. Earnings per share over the same trailing period were ₹49.57.
Colgate Palmolive (India) reported borrowings of ₹46.88 Cr at Mar 2026, against cash and equivalents of ₹1,470 Cr.
Cash from operations was ₹1,810 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1,727 Cr.